No change
0.07%
Add to watchlist
Create an alert
Stocks and Shares ISAMilestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.
Company Information
About this company
Key people
Joseph Oliveto
President, Chief Executive Officer, Director
Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Jeffrey Nelson
Chief Operating Officer
David Bharucha
Chief Medical Officer
Lorenz Muller
Chief Commercial Officer
Robert James Wills
Non-Executive Independent Chairman of the Board
Stuart Duty
Independent Director
Seth H. Z. Fischer
Independent Director
Lisa M. Giles
Independent Director
Joseph C. Papa
Independent Director
Click to see more
Key facts
- Shares in issue85.17m
- EPICMIST
- ISINCA59935V1076
- LocationCanada
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$172.04m
- Employees33
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.